Frespas MF 80mg/250mg Tablet
Marketer
Pharmasynth Formulations Ltd
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Frespas MF 80mg/250mg Tablet
Abdominal pain is effectively treated with the combined medication, Frespas MF 80mg/250mg Tablet. This formulation alleviates abdominal pain, bloating, discomfort, and cramping by relaxing the gastrointestinal tract's muscles and inhibiting pain-inducing neurotransmitters. Administered with food, the dosage and duration of Frespas MF 80mg/250mg Tablet should strictly adhere to your physician's instructions. Treatment should continue as directed; premature discontinuation may lead to symptom recurrence and condition exacerbation. Inform your healthcare provider of all other medications you are currently using, as interactions are possible. Common, typically transient side effects include diarrhea, nausea, vomiting, stomach upset, dry mouth, appetite loss, thirst, and heartburn. Report any concerning side effects immediately. Dizziness and drowsiness are also possible; avoid driving or activities requiring concentration until the medication's effects are known. Alcohol consumption should be avoided due to potential dizziness exacerbation. Disclose any pregnancy, pregnancy plans, breastfeeding, or kidney/liver conditions prior to commencing treatment to ensure appropriate dosage.
Primary Ingredients of Frespas MF 80mg/250mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Frespas MF 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Frespas MF 80mg/250mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 80mg/250mg Frespas MF Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medicine with a meal.
Common Side effects of Frespas MF 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Frespas MF 80mg/250mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Frespas MF 80mg/250mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.
How Frespas MF 80mg/250mg Tablet works:
Each Frespas MF 80mg/250mg tablet unites Drotaverine and Mefenamic Acid to alleviate abdominal discomfort and cramping. Drotaverine, an antispasmodic, targets and relaxes abdominal smooth muscle contractions. Mefenamic Acid, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of pain- and inflammation-inducing substances, thus reducing swelling and pain in the abdomen.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with Frespas MF 80mg/250mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Frespas MF 80mg/250mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Frespas MF 80mg/250mg Tablet while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Frespas MF 80mg/250mg Tablets, a potential side effect of the medication, including the possibility of dizziness.
KidneyCAUTION
Patients with impaired kidney function should use Frespas MF 80mg/250mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Frespas MF 80mg/250mg tablets are contraindicated in individuals with severely compromised renal function.
LiverCAUTION
Patients with hepatic impairment should use Frespas MF 80mg/250mg tablets cautiously, as dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Frespas MF 80mg/250mg Tablet :
Should you forget a dose of Frespas MF 80mg/250mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Frespas MF 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
3,018 People bought this recently